BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19288861)

  • 1. [Molecular mechanisms of ALS-linked mutant SOD1-induced motor neuron death].
    Nishitoh H; Ichijo H
    Tanpakushitsu Kakusan Koso; 2009 Mar; 54(3):237-44. PubMed ID: 19288861
    [No Abstract]   [Full Text] [Related]  

  • 2. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
    Oh YK; Shin KS; Yuan J; Kang SJ
    J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.
    Nishitoh H; Kadowaki H; Nagai A; Maruyama T; Yokota T; Fukutomi H; Noguchi T; Matsuzawa A; Takeda K; Ichijo H
    Genes Dev; 2008 Jun; 22(11):1451-64. PubMed ID: 18519638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.
    Kirby J; Halligan E; Baptista MJ; Allen S; Heath PR; Holden H; Barber SC; Loynes CA; Wood-Allum CA; Lunec J; Shaw PJ
    Brain; 2005 Jul; 128(Pt 7):1686-706. PubMed ID: 15872021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of N19S-SOD1, an SOD1 mutant found in sporadic amyotrophic lateral sclerosis patients, induces low-grade motoneuronal toxicity.
    Obata Y; Niikura T; Kanekura K; Hashimoto Y; Kawasumi M; Kita Y; Aiso S; Matsuoka M; Nishimoto I
    J Neurosci Res; 2005 Sep; 81(5):720-9. PubMed ID: 16035108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOD1 mutant protein gets loose in ALS.
    McCaffrey P
    Lancet Neurol; 2006 Feb; 5(2):119. PubMed ID: 16456939
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicity of ALS-linked SOD1 mutants.
    Williamson TL; Corson LB; Huang L; Burlingame A; Liu J; Bruijn LI; Cleveland DW
    Science; 2000 Apr; 288(5465):399. PubMed ID: 10798964
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection method of the adjacent motor neuronal death in an in vitro co-culture model of familial ALS-associated Cu/Zn superoxide dismutase.
    Park KS; Kim HJ; Choi WJ; Kim M; Lee KW
    Biotechnol Lett; 2004 Aug; 26(15):1201-5. PubMed ID: 15289674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death signalling pathway in mice motoneurons is unique and sensitive in those expressing ALS mutant SOD1.
    Reilly CE
    J Neurol; 2002 Dec; 249(12):1756-8. PubMed ID: 12683398
    [No Abstract]   [Full Text] [Related]  

  • 10. Are all new data referring to amyotrophic lateral sclerosis certain? Some doubts.
    Rafałowska J
    Folia Neuropathol; 2001; 39(4):261-4. PubMed ID: 11928897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
    Clement AM; Nguyen MD; Roberts EA; Garcia ML; Boillée S; Rule M; McMahon AP; Doucette W; Siwek D; Ferrante RJ; Brown RH; Julien JP; Goldstein LS; Cleveland DW
    Science; 2003 Oct; 302(5642):113-7. PubMed ID: 14526083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
    Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Model System Offers Clues to ALS.
    Kuehn BM
    JAMA; 2011 Oct; 306(14):1534. PubMed ID: 21990293
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.
    Barber SC; Shaw PJ
    Free Radic Biol Med; 2010 Mar; 48(5):629-41. PubMed ID: 19969067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis: all roads lead to Rome.
    Gonzalez de Aguilar JL; Echaniz-Laguna A; Fergani A; René F; Meininger V; Loeffler JP; Dupuis L
    J Neurochem; 2007 Jun; 101(5):1153-60. PubMed ID: 17250677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALS: a disease of motor neurons and their nonneuronal neighbors.
    Boillée S; Vande Velde C; Cleveland DW
    Neuron; 2006 Oct; 52(1):39-59. PubMed ID: 17015226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
    Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
    Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.